1. Home
  2. KOD vs FT Comparison

KOD vs FT Comparison

Compare KOD & FT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KOD
  • FT
  • Stock Information
  • Founded
  • KOD 2009
  • FT 1988
  • Country
  • KOD United States
  • FT United States
  • Employees
  • KOD N/A
  • FT N/A
  • Industry
  • KOD Biotechnology: Biological Products (No Diagnostic Substances)
  • FT Trusts Except Educational Religious and Charitable
  • Sector
  • KOD Health Care
  • FT Finance
  • Exchange
  • KOD Nasdaq
  • FT Nasdaq
  • Market Cap
  • KOD 186.3M
  • FT 189.6M
  • IPO Year
  • KOD 2018
  • FT N/A
  • Fundamental
  • Price
  • KOD $8.72
  • FT $7.28
  • Analyst Decision
  • KOD Hold
  • FT
  • Analyst Count
  • KOD 5
  • FT 0
  • Target Price
  • KOD $6.80
  • FT N/A
  • AVG Volume (30 Days)
  • KOD 484.9K
  • FT 63.0K
  • Earning Date
  • KOD 11-14-2024
  • FT 01-01-0001
  • Dividend Yield
  • KOD N/A
  • FT 7.85%
  • EPS Growth
  • KOD N/A
  • FT N/A
  • EPS
  • KOD N/A
  • FT N/A
  • Revenue
  • KOD N/A
  • FT N/A
  • Revenue This Year
  • KOD N/A
  • FT N/A
  • Revenue Next Year
  • KOD N/A
  • FT N/A
  • P/E Ratio
  • KOD N/A
  • FT N/A
  • Revenue Growth
  • KOD N/A
  • FT N/A
  • 52 Week Low
  • KOD $2.19
  • FT $5.97
  • 52 Week High
  • KOD $11.60
  • FT $7.23
  • Technical
  • Relative Strength Index (RSI)
  • KOD 64.72
  • FT 20.83
  • Support Level
  • KOD $8.03
  • FT $7.59
  • Resistance Level
  • KOD $9.55
  • FT $7.78
  • Average True Range (ATR)
  • KOD 0.89
  • FT 0.12
  • MACD
  • KOD -0.08
  • FT -0.06
  • Stochastic Oscillator
  • KOD 36.51
  • FT 8.00

About KOD Kodiak Sciences Inc

Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is KSI-301, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD.

About FT Franklin Universal Trust

Franklin Universal Trust is a closed-end management investment company. Its primary investment objective is to provide high, current income consistent with the preservation of capital. Its secondary objective is the growth of income through dividend increases and capital appreciation. The fund invests in two asset classes being the high yield bonds and utility stocks.

Share on Social Networks: